COPD trials in Romania

In Romania 10 Also abroad 559

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Where
Bucharest, Cluj-Napoca, Craiova, Oradea, Timișoara
Age
40 years to 75 years
People
606 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Brasov, Cluj-Napoca, Oradea
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Bucharest, Cluj-Napoca, Oradea, Timisoara, Timișoara
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
Phase 2Not yet taking people in Romania
A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
Where
Bucharest, Cluj-Napoca
Age
18 years and over
People
183 worldwide
Run by
Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Where
Bacau, Bucharest, Cluj Napoca, Cluj-Napoca, Oradea, Palazu Mare, Timisoara, Timis
Age
40 years to 80 years
People
961 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Bucharest, Cluj-Napoca, Negresti-Oas, Oradea, Regiunea Oltenia, Târgu Mureş, Timisoara, Timișoara
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
No phaseTaking people
Cognitive Load and Inhaler Technique in COPD
Where
Timișoara
Age
18 years to 100 years
People
100
Run by
Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara
See details and how to joinNCT07786220
Phase 3Taking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Bucharest, Timisoara
Age
40 years to 75 years
People
1,196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
No phaseNot yet taking people in Romania
Design, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma
Where
Brasov, Bucharest, Suceava, Timișoara
Age
10 years to 19 years
People
42
Run by
University Children's Hospital Basel
See details and how to joinNCT07472283
No phaseTaking people
Integrated Approach in Frail Older People with Atrial Fibrillation
Where
Bucharest
Age
65 years and over
People
1,250 worldwide
Run by
Heart Care Foundation
See details and how to joinNCT06775028